C22orf13 抗体 (AA 51-150) (Biotin)
-
- 抗原 See all C22orf13 (GUCD1) products
- C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))
-
抗原表位
- AA 51-150
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This C22orf13 antibody is conjugated to Biotin
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 交叉反应
- 人
- 预测反应
- Mouse,Rat,Dog,Horse
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human C22orf13
- 亚型
- IgG
-
anti-Guanylyl Cyclase Domain Containing 1 (GUCD1) (AA 1-136) antibody
GUCD1 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Guanylyl Cyclase Domain Containing 1 (GUCD1) (AA 81-130) antibodyGUCD1 适用: 人, 豚鼠 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C for 12 months.
- 有效期
- 12 months
-
- 抗原
- C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))
- 别名
- C22orf13 (GUCD1 产品)
- 别名
- C22orf13 antibody, LLN4 antibody, 1110038D17Rik antibody, C17H22orf13 antibody, wu:fi27d12 antibody, zgc:152874 antibody, guanylyl cyclase domain containing 1 antibody, GUCD1 antibody, Gucd1 antibody, gucd1 antibody
- 背景
-
Synonyms: C22orf13, CG13760 gene product [Drosophila melanogaster] homolog, Chromosome 22 open reading frame 13, CV013_HUMAN, LLN4, MGC1842, OTTHUMP00000198388, Protein LLN4, Uncharacterized protein C22orf13.
Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf13 gene product has been provisionally designated C22orf13 pending further characterization.
- 基因ID
- 83606
-
